Your browser doesn't support javascript.
loading
DOACs in Valvular Heart Disease: Latest Key Updates on PROACT Xa (Apixaban) and INVICTUS (Rivaroxaban).
Ryu, Rachel.
Affiliation
  • Ryu R; College of Pharmacy, 6645Western University of Health Sciences, Pomona, CA, USA.
Clin Appl Thromb Hemost ; 28: 10760296221144044, 2022.
Article in En | MEDLINE | ID: mdl-36474349
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rivaroxaban / Heart Valve Diseases Limits: Humans Language: En Journal: Clin Appl Thromb Hemost Journal subject: ANGIOLOGIA Year: 2022 Document type: Article Affiliation country: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rivaroxaban / Heart Valve Diseases Limits: Humans Language: En Journal: Clin Appl Thromb Hemost Journal subject: ANGIOLOGIA Year: 2022 Document type: Article Affiliation country: Estados Unidos